HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Surgical Wound Fluid From Elderly Patients Shows a Dramatically Reduced Potential to Stimulate In-vitro Recruitment and Differentiation of Endothelial Progenitor Cells: Role of VEGF-165 and TGF-β1.

AbstractUNLABELLED:
Purpose. Elderly patients are susceptible to wound healing problems due to impaired neovascularisation in tissue repair. We investigated influence of surgical wound fluid (WF) obtained from both young and aged patients after musculoskeletal surgery on in-vitro recruitment and differentiation of endothelial progenitor cells (EPCs). Further, VEGF and TGF-b1 in WF were measured and blockade experiments were performed to analyze the role of both cytokines in EPC recruitment.
METHODS:
WF was obtained from young (28 ± 5 years, n = 14) and elderly (74 ± 8 years, n = 15) patients at 3, 8, and 24 hours after surgery. EPCs were isolated from healthy donors and incubated (72 hours) in medium substituted by WF. EPC number/differentiation was determined by fluorescence-microscopy and flow-cytometry after staining for DiLDL and lectin. CBF or ELISA was used to measure VEGF and TGF-b1 in WF. For blockade experiments, WF was mixed with antibodies against VEGF/TGF-b1 before incubation.
RESULTS:
A significantly higher number and increased differentiation of EPC can be observed after incubation with WF from young compared to elderly individuals. VEGF and TGF-b1 were higher in young patients' WF, and blockade of both cytokines reduced EPC numbers significantly.
CONCLUSION:
Impaired wound healing in the elderly could be a result of dampened recruitment of EPC to site of affliction, possibly due to low VEGF/TGF-b1 levels.  .
AuthorsMaciej Janusz Powerski, Dirk Henrich, Daniel Wastl, Anna Sander, Ingo Marzi
JournalWounds : a compendium of clinical research and practice (Wounds) Vol. 22 Issue 8 Pg. 204-11 (Aug 2010) ISSN: 1044-7946 [Print] United States
PMID25901514 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: